Literature DB >> 30243902

The functional potency of natural killer cells in response to IL-2/IL-15/IL-21 stimulation is limited by a concurrent upregulation of Tim-3 in bladder cancer.

Wei Zhang1, Huan Feng1, Qichao Chen1, Xiaozhe Lu1, Jingping Ge2.   

Abstract

For reasons not completely clear, natural killer (NK) cells from tumor patients displayed multiple exhaustion features and could not be completely restored even when the inhibitory signals from the intratumoral environment had ceased to exist. Here, we found that the circulating NK cells from bladder cancer patients presented significantly reduced cytotoxicity than the circulating NK cells from healthy volunteers. This impairment in cytotoxicity resulted in part from an overrepresentation of Tim-3+ NK cells in bladder cancer patients. Interestingly, patients with higher frequency of Tim-3+ NK cells tended to present higher frequency of Gal-9+ cells in tumor. Exogenous Gal-9 significantly reduced the cytotoxicity of Tim-3+, but not Tim-3-, NK cells. Patients with better prognosis presented lower levels of Tim-3+ NK cells and Gal-9+ tumor cells. We then attempted to improve the cytotoxicity of NK cells using a combination of exogenous cytokines. IL-2 + IL-15 and IL-2 + IL-21 significantly enhanced, but could not completely restore, the cytotoxicity of NK cells in bladder cancer patients. Notably, when the cytokine concentration increased from intermediate levels to high levels, the cytotoxicity of NK cells from healthy volunteers significantly increased with a strong upward trend, whereas the cytotoxicity of NK cells from bladder cancer patients plateaued at intermediate levels. Further examination revealed that high cytokine concentration significantly increased the Tim-3 expression in NK cells from bladder cancer patients. Blocking Tim-3 not only improved the cytotoxicity of NK cells from bladder cancer patients, but also eliminated the plateauing effect when the NK cells were stimulated with high concentrations of cytokines. Together, these data suggested that proinflammatory cytokines could moderately improve NK cell cytotoxicity in bladder cancer patients. However, the effect was limited due to a concurrent upregulation of Tim-3.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Natural killer cell; Tim-3

Mesh:

Substances:

Year:  2018        PMID: 30243902     DOI: 10.1016/j.yexcr.2018.09.013

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering.

Authors:  Olaf Oberschmidt; Michael Morgan; Volker Huppert; Joerg Kessler; Tanja Gardlowski; Nadine Matthies; Krasimira Aleksandrova; Lubomir Arseniev; Axel Schambach; Ulrike Koehl; Stephan Kloess
Journal:  Hum Gene Ther Methods       Date:  2019-05-16       Impact factor: 2.396

Review 2.  The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy.

Authors:  Haoyu Sun; Cheng Sun
Journal:  Front Immunol       Date:  2019-10-17       Impact factor: 7.561

Review 3.  Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy.

Authors:  Cai Zhang; Yuxia Liu
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

Review 4.  Immune Checkpoints and Innate Lymphoid Cells-New Avenues for Cancer Immunotherapy.

Authors:  Nicolas Jacquelot; Maryam Ghaedi; Kathrin Warner; Douglas C Chung; Sarah Q Crome; Pamela S Ohashi
Journal:  Cancers (Basel)       Date:  2021-11-27       Impact factor: 6.639

5.  Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer.

Authors:  S H Petersen; L F Kua; S Nakajima; W P Yong; K Kono
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

Review 6.  Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?

Authors:  Aviad Ben-Shmuel; Guy Biber; Mira Barda-Saad
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.